Stocks / NASDAQ / Kiromic BioPharma Inc.

Kiromic BioPharma Inc.

Our Opinion

Kiromic BioPharma Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company mentioned on its website that they use animals for product testing.

“This results in synergistically strong T-cell activity, as shown in Kiromic’s animal studies which demonstrate spectacular tumor cell killing capabilities.” Read the following article

Company Description

Kiromic BioPharma, Inc. is a preclinical stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing immuno-oncology applications through its product pipeline. It is developing a range of product candidates for the treatment of blood cancers and solid tumors.

Company Website: